Navigation Links
MINRAD International, Inc. Announces Change in Distribution Agreement with RxElite Holdings, Inc.
Date:9/11/2008

pany; its dependence on key personnel; its need to attract and retain technical and managerial personnel; its ability to execute its business strategy; the intense competition it faces; its ability to protect its intellectual property and proprietary technologies; its exposure to product liability claims resulting from the use of its products; general economic and capital market conditions; financial conditions of its customers and their perception of its financial condition relative to that of its competitors; as well as those risks described under the heading "Risk Factors" of Minrad International's Form 10-KSB/A, filed with the Securities and Exchange Commission on April 21, 2008. Although Minrad International, Inc. believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct.


'/>"/>
SOURCE MINRAD International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. MINRAD International, Inc. Announces Appointment of Charles R. Trego, Jr. to CFO & EVP
2. MINRAD International, Inc. Announces the Start of the MINRAD International Distributor Meeting in Cape Town, South Africa
3. MINRAD International, Inc. to Discuss 2007 Fourth Quarter and Full Year Financial Results on Monday, March 31, 2008
4. MINRAD International, Inc. Announces 2007 Financial Results
5. MINRAD International, Inc. Announces FDA Approval of Petrem(TM) Sevoflurane
6. MINRAD International, Inc. to Discuss 2008 Second Quarter Financial Results on Thursday, August 14, 2008
7. Clarity Imaging International, Inc. Rolls Out Mobile DEXA Program
8. Arrow International, Inc. Invites You to Join Its 2007 Annual Meeting of Shareholders on the Web
9. Natural Alternatives International, Inc. Announces Late Filing of its Annual Report on Form 10-K, Revenue for Fiscal 2007 and Guidance on First Quarter of Fiscal 2008
10. Cryo-Cell International, Inc. Reports Third Quarter 2007 Results
11. TenderCare International, Inc. Announces Signing of Merger Agreement with the Hain Celestial Group for All Outstanding Shares of TenderCare Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)WASHINGTON, Dec. 4 In response to the U.S. Justice Department Drug Enforcement Agency,s (DEA) classification of boldione, desoxymethyltestosterone, and 19-nor-4,9(10)-androstadienedione as "anabolic
(Date:12/4/2009)STANFORD, Calif. A new study shows that muscle cells grown in the lab can restore an intestine,s ability to squeeze shut properly. The work, performed in dogs and rats, might ultimately help treat pa
(Date:12/4/2009)Case Western Reserve University researchers, from the School of Medicine,s Department of Nutrition, discovered two new metabolic pathways by which products of lipid peroxidation and some drugs of abus
(Date:12/4/2009)Rockville, MD "Why is it that men can be bastards and women must wear pearls and smile?" wrote author Lynn Hecht Schafran. The answer, according to an article in the Journal of Vision , may lie in
(Date:12/4/2009)Outcomes same whether procedure done immediately or 3 weeks later, study shows , , FRIDAY, Dec. 4 (HealthDay News) -- Timing of surgical repair or reconstruction of multiple-ligament knee inju
Breaking Medicine News(10 mins):Health News:Natural Products Association Issues Statement on DEA's Steroid Classification Action 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 2Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 3Health News:Muscle cell infusion shown to strengthen sphincters in animals in Stanford study 4Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Are angry women more like men? 2Health News:Timing of Multiple-Ligament Knee Surgery May Not Matter 2
...g her current rehab stint pretty 'serious' and doe...riend of the 'Mean Girls' star said that the actre... that there is no clear time frame for her stay du...he is taking rehab very seriously this time and no...
...ngham (UAB) have traced the differences and simila...nd that in human RNA , a significant development t...biotic resistance. The new findings have b...s the key enzyme regulating the transfer of geneti...
...d that a particular resonance pattern in the brain...ility to discriminate speech. In the June... Huan Luo report that the inherent rhythm of neura...lation of this frequency provides further evidence...
...shaped nano-particle called buckyball has been ide...ckyball has the ability to block allergic reaction... possible. Allergic disease is the sixth le...se findings advance the up-and-coming field of med...
...o stun people with the way she looks, for the pop ...ms in one month . The 26-year-old is on a s...her celeb trainer Harley Pasternak, and she even g... after personal trainer. Earlier Vanessa Wi...
... cosmetics everyday to look their best, but this e...heir bodies. A new study has found that wo...y 5lb of chemicals a year into their bodies. ...nd toiletries means that a cocktail of 4lb 6oz of ...
Other Medicine News:Health News:Scientists Trace New Pathway That may Stem Antibiotic Resistance 2Health News:Buckyball Has the Ability to Fight Against Allergy: Research 2Health News:Excessive Use of Cosmetics Leads to Adverse Effects on the Body 2
(Date:12/4/2009)BETHESDA, Md., Dec. 4 Drs. Neal Shore and E. David Crawford presented results for prostate-specific antigen (PSA) recurrence from the additional analysis of secondary end points of biochemical recurr
(Date:12/3/2009)NEW YORK, Dec. 3 Guidepoint Global, LLC , a leading primary research firm, today announced the launch of their Sleep Apnea Tracker, a monthly longitudinal data release that monitors and projects tre
(Date:12/3/2009)SUNNYVALE, Calif., Dec. 3 Pharmacyclics, Inc. (Nasdaq: PCYC ), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of immune media
Breaking Medicine Technology:Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 2Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 3Degarelix (FIRMAGON(R)) vs Leuprolide (Lupron Depot(R)) in Patients With Advanced Prostate Cancer: Further Analysis From a Phase III Pivotal Trial 4Leading Primary Research Firm Guidepoint Global Announces Launch of Sleep Apnea Tracker 2Pharmacyclics to Host Webcast and Conference Call to Discuss Clinical Updates on Its HDAC and BTK Program as Presented at The American Society of Hematology Meeting Dec. 6 & 7 2Childbirth May Slow Progression of Multiple Sclerosis 62015 1Childbirth May Slow Progression of Multiple Sclerosis 62015 2Childbirth May Slow Progression of Multiple Sclerosis 62015 3DNA Genotek Launches Global Partner Program 14953 1DNA Genotek Launches Global Partner Program 14953 2DNA Genotek Launches Global Partner Program 14953 3Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 1Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 2Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 3
... Company to Submit a Supplemental New Drug Applica..., Pa., April 6 Cephalon, Inc . (Nasdaq: CEPH )...ee clinical trial of NUVIGIL(R) (armodafinil) Tabl... associated with jet lag disorder. Based on these...w Drug Application with the U.S. Food and Drug Adm...
...pril 3 Torax Medical Inc., a medical device compa...gastroesophageal reflux disease (GERD) has commenc... Management System. The trial, which is being con...centers in the U.S. and Europe, will evaluate the ...ients suffering from GERD despite medical therapy....
Other Medicine Technology:Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 2Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 3Cephalon Announces Positive Results from a Phase Three Study of NUVIGIL in Jet Lag Disorder 4Torax Medical Launches Pivotal Clinical Study of New Acid Reflux Treatment 2
New Image Cut-to-Fit Convex FlexWear Skin Barrier
New Image Closed Mini Pouch
CenterPointLock Stoma Irrigator Drain
CenterPointLock Sterile Drainable Kits
Medicine Products: